COMMUNIQUÉS West-GlobeNewswire

Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
09/10/2025
Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for AD04 development GLEN ALLEN, Va., Oct. 09, 2025 ( [...]
Digital Utilities Ventures Completes Acquisition and Name Change
09/10/2025
Planned uplist to OTCQB Venture Exchange, if approved will follow completion of audit and previously announced reverse split MANKATO, Minn., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV [...]
Akari Therapeutics Files Two New Patents for Immuno-Oncology Mode of Action for Novel ADC Platform Utilizing Spliceosome Modulating Payload PH1
09/10/2025
BOSTON and LONDON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that it has filed [...]
Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
09/10/2025
With over 120 issued and pending patent applications, Autonomix is building a comprehensive, global IP portfolio in nerve-sensing and modulation Newly issued patent strengthens the Company’s strategic position in a [...]
Journal of Clinical Microbiology Studies Demonstrate Two Investigational Diagnostics Outperform Current Tests in Detecting Early Lyme Disease
09/10/2025
Studies utilize Bay Area Lyme Foundation’s Lyme Disease Biobank samples to point to promise of single-tier diagnostics to potentially transform early detection PORTOLA VALLEY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- [...]
Doheny Eye Institute Announces Upcoming Presentations at the American Academy of Ophthalmology 2025 Annual Meeting
09/10/2025
Doheny-UCLA clinician-scientists selected to deliver more than 25 presentations and talks PASADENA, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research [...]
Safety Shot, Inc. to Become Bonk, Inc., to Trade on Nasdaq Under New Ticker Symbol “BNKK”
09/10/2025
Rebranding Solidifies Company’s Full Strategic Transformation into the Premier Public Vehicle for the BONK Ecosystem SCOTTSDALE, AZ, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company”) [...]
Children's National Hospital receives $8 million grant from Gilbert Family Foundation to advance neurofibromatosis research
09/10/2025
The investment deepens a partnership to transform care for one of the most common genetic conditions in children Washington, DC, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Children’s National Hospital and the Gilbert Family [...]
Legend Senior Living® Grows Florida Footprint With Renaissance of North Tampa
09/10/2025
WICHITA, Kan., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living®, a nationally recognized senior living provider based in Wichita, KS, has announced the management of Renaissance North Tampa, expanding its Florida [...]
Foundation Health Secures $20M Series A to Scale AI-Powered Infrastructure for Pharmacy Operations, Care Coordination, and Direct-to-Patient Delivery
09/10/2025
Funding Supports Expansion of PAIGE AI Pharmacist Assistant, Driving Intelligent Automation for Prior Authorizations and Patient Communication Comprehensive Platform Reduces Manual Pharmacy Workflows by Up to 75% While [...]
Triumph Steps Launches CLE-Eligible Mental Fitness Program for Lawyers
09/10/2025
Program Aligns with World Mental Health Day, Offering Attorneys a Path to Wellness, Ethics, and Emotional Resilience Miami, Florida, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Triumph Steps , a leading provider of emotional [...]
Optime Care Terminates Distributor Agreement for Korlym® (mifepristone)
09/10/2025
ST. LOUIS, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Following 10+ years of service to Cushing's syndrome patients, Optime Care , a national specialty pharmacy, distribution and patient management organization maximizing [...]
Toro Neurovascular and Kaneka Announce Exclusive U.S. Distribution Partnership
09/10/2025
Partnership to Enable U.S. Access to Toro’s Novel Neurovascular Catheter Portfolio Pending Regulatory Approval IRVINE, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Toro Neurovascular, a company pioneering advanced catheter [...]
Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer
09/10/2025
Pioneering Evidence-Based AI Innovation in Personalized Wellness and Health Research VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY [...]
Applications Now Open for Fall 2025 First Practice Fund Scholarship
09/10/2025
ST. LOUIS and HINTON, West Virginia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- PracticeLink , the nation’s most trusted physician recruitment resource and home of the most widely used online physician job board, is proud to [...]
Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando
09/10/2025
Results from the study of oral gildeuretinol in moderate Stargardt disease to be presented as late-breaker during Retina Subspecialty Day CAMBRIDGE, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc [...]
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
09/10/2025
Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse models CAMBRIDGE, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT [...]
Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer
09/10/2025
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the [...]
Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial
09/10/2025
STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]

Pages